ReproCELL Incorporated Logo

ReproCELL Incorporated

Provider of stem cell technology and services for research and regenerative medicine.

4978 | T

Overview

Corporate Details

ISIN(s):
JP3974770004
LEI:
Country:
Japan
Address:
横浜市港北区新横浜3−8−11

Description

ReproCELL Incorporated is a global company providing solutions for preclinical and clinical research, with a primary focus on stem cell technology, drug discovery, and regenerative medicine. The company's portfolio includes a wide range of products such as induced pluripotent stem cells (iPSCs), differentiated cells, 3D cell culture models, and specialized reagents like RNA-based reprogramming kits that avoid genomic integration. ReproCELL also offers extensive contract research services, including human tissue assays for evaluating drug efficacy and safety. A key area of expertise is the GMP-compliant manufacturing of clinical-grade iPSCs and iPSC-derived mesenchymal stem cells (iMSCs), supporting the development of advanced cell therapies. The company's tools and services are designed to help academic and commercial scientists accelerate the translation of research into clinical applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2019-06-28 06:44
有価証券報告書-第17期(平成30年4月1日-平成31年3月31日)
Japanese ZIP 1.1 MB
2019-02-13 08:35
四半期報告書-第17期第3四半期(2018/10/01-2018/12/31)
Japanese ZIP 163.5 KB
2018-11-13 07:06
四半期報告書-第17期第2四半期(2018/07/01-2018/09/30)
Japanese ZIP 195.8 KB
2018-08-10 08:55
四半期報告書-第17期第1四半期(2018/04/01-2018/06/30)
Japanese ZIP 198.7 KB
2018-06-25 09:26
有価証券報告書-第16期(平成29年4月1日-平成30年3月31日)
Japanese ZIP 1.1 MB
2018-02-09 07:51
四半期報告書-第16期第3四半期(2017/10/01-2017/12/31)
Japanese ZIP 153.3 KB
2017-11-10 07:24
四半期報告書-第16期第2四半期(2017/07/01-2017/09/30)
Japanese ZIP 187.7 KB
2017-08-10 08:11
四半期報告書-第16期第1四半期(2017/04/01-2017/06/30)
Japanese ZIP 178.4 KB
2017-06-26 08:45
有価証券報告書-第15期(2016/04/01-2017/03/31)
Japanese ZIP 1.2 MB
2017-02-13 07:17
四半期報告書-第15期第3四半期(2016/10/01-2016/12/31)
Japanese ZIP 210.4 KB
2016-11-11 08:08
四半期報告書-第15期第2四半期(2016/07/01-2016/09/30)
Japanese ZIP 204.0 KB
2016-08-12 08:14
四半期報告書-第15期第1四半期(2016/04/01-2016/06/30)
Japanese ZIP 161.4 KB
2016-06-27 08:34
有価証券報告書-第14期(2015/04/01-2016/03/31)
Japanese ZIP 1.7 MB
2016-06-17 05:21
訂正四半期報告書-第14期第3四半期(2015/10/01-2015/12/31)
Japanese ZIP 148.7 KB
2016-02-12 08:23
四半期報告書-第14期第3四半期(2015/10/01-2015/12/31)
Japanese ZIP 201.0 KB

Automate Your Workflow. Get a real-time feed of all ReproCELL Incorporated filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ReproCELL Incorporated

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ReproCELL Incorporated via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Initiator Pharma A/S Logo
Clinical-stage company developing drugs for central and peripheral nervous system needs.
Denmark
INIT
Inmolecule Nanotech, S.A. Logo
Develops nanoparticles from plant compounds for biomedical and personal care products.
Spain
MLINA
Inotiv, Inc. Logo
A CRO providing nonclinical drug development services and research models.
United States of America
NOTV
IntegraGen Logo
Provides genomic services for cancer and rare diseases, translating research to practice.
France
ALINT
Intellia Therapeutics, Inc. Logo
A clinical-stage genome editing company developing therapeutics using CRISPR/Cas9.
United States of America
NTLA
InterDigital, Inc. Logo
An R&D company licensing foundational technologies for mobile, video, and AI.
United States of America
IDCC
IntoCell, Inc. Logo
Develops platform technologies for Antibody-Drug Conjugates (ADCs) for oncology.
South Korea
287840
Inventage Lab Inc. Logo
Biopharmaceutical company developing advanced drug delivery systems.
South Korea
389470
Investeko Spolka Akcyjna Logo
Specializes in environmental protection and sustainable business solutions.
Poland
IVE
IQVIA HOLDINGS INC. Logo
Provider of analytics, tech solutions, and clinical research for life sciences.
United States of America
IQV

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.